CDH2 and cancer: Following periostin treatment, qRT-PCR and Western blot analysis revealed induction of the EMT process by a shift in expression of cancer cells from epithelial (E-cadherin) to mesenchymal phenotypes (N-cadherin, vimentin, and Twist) (Figure 2A-2C).